US Bancorp’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.7K Hold
1,000
﹤0.01% 2679
2026
Q1
$52.3K Hold
1,000
﹤0.01% 2690
2025
Q4
$51.2K Hold
1,000
﹤0.01% 2692
2025
Q3
$38.9K Hold
1,000
﹤0.01% 2785
2025
Q2
$30.1K Hold
1,000
﹤0.01% 3011
2025
Q1
$28.5K Hold
1,000
﹤0.01% 3016
2024
Q4
$33K Hold
1,000
﹤0.01% 2935
2024
Q3
$37.3K Hold
1,000
﹤0.01% 2877
2024
Q2
$33.6K Hold
1,000
﹤0.01% 2855
2024
Q1
$35.8K Hold
1,000
﹤0.01% 2858
2023
Q4
$32.9K Sell
1,000
-770
-44% -$20.7K ﹤0.01% 2862
2023
Q3
$48.2K Buy
1,770
+770
+77% +$23.2K ﹤0.01% 2459
2023
Q2
$31.6K Hold
1,000
﹤0.01% 2744
2023
Q1
$27.2K Hold
1,000
﹤0.01% 2825
2022
Q4
$30.4K Hold
1,000
﹤0.01% 2779
2022
Q3
$30K Hold
1,000
﹤0.01% 2816
2022
Q2
$28K Hold
1,000
﹤0.01% 2881
2022
Q1
$34K Hold
1,000
﹤0.01% 2817
2021
Q4
$42K Hold
1,000
﹤0.01% 2743
2021
Q3
$45K Hold
1,000
﹤0.01% 2706
2021
Q2
$49K Hold
1,000
﹤0.01% 2691
2021
Q1
$50K Hold
1,000
﹤0.01% 2585
2020
Q4
$51K Sell
1,000
-1,400
-58% -$66.6K ﹤0.01% 2505
2020
Q3
$99K Hold
2,400
﹤0.01% 2094
2020
Q2
$100K Buy
2,400
+1,400
+140% +$55.2K ﹤0.01% 2107
2020
Q1
$31K Hold
1,000
﹤0.01% 2569
2019
Q4
$42K Buy
+1,000
New +$37.1K ﹤0.01% 2559

Other funds holding SBIO

US Bancorp's SBIO Position: Q2 2026 in Review

US Bancorp held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 1,000 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2679.

US Bancorp first reported a position in SBIO in Q4 2019 and has held it in 27 quarters since. The position peaked at $100K in Q2 2020. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • US Bancorp held 1,000 shares of ALPS Medical Breakthroughs ETF worth $64.7K as of Q2 2026.
  • US Bancorp left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2679 holding.
  • US Bancorp first reported a position in ALPS Medical Breakthroughs ETF in Q4 2019 and has held it in 27 quarters since.
  • US Bancorp's ALPS Medical Breakthroughs ETF position peaked at $100K in Q2 2020.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.